# FBXL12

## Overview
FBXL12 is a gene that encodes the F-box and leucine-rich repeat protein 12, a member of the F-box protein family. This protein is a crucial component of the Skp-cullin-F box (SCF) ubiquitin-ligase complex, which plays a significant role in the regulation of the cell cycle by targeting specific proteins for ubiquitination and subsequent proteasomal degradation. FBXL12 specifically mediates the degradation of calmodulin kinase I (CaMKI), influencing the assembly and activity of the cyclin D1/cdk4 complex, and thereby affecting cell cycle progression and cellular homeostasis (Mallampalli2013Fbxl12). The protein's involvement in these processes highlights its potential as a target for therapeutic interventions, particularly in conditions characterized by dysregulated cell growth, such as cancer (Tsuruta2016SCFFbl12; Mallampalli2013Fbxl12).

## Function
FBXL12 is a crucial component of the Skp-cullin-F box (SCF) ubiquitin-ligase complex, which plays a significant role in regulating cell cycle progression. It specifically mediates the degradation of calmodulin kinase I (CaMKI) through a proteasome-directed pathway, leading to G1 arrest in lung epithelial cells (Mallampalli2013Fbxl12). This degradation process disrupts the assembly of the cyclin D1/cdk4 complex, which is essential for the transition from the G0 to S phase of the cell cycle (Mallampalli2013Fbxl12).

FBXL12 influences the phosphorylation of p27, a cyclin-dependent kinase inhibitor, at specific threonine residues. This phosphorylation is crucial for the stabilization and localization of the cdk4/cyclin D1/p27 complex, affecting its activity and subcellular localization (Mallampalli2013Fbxl12). By modulating the stability and activity of CaMKI, FBXL12 indirectly regulates the cell cycle and maintains cellular homeostasis, preventing uncontrolled cell division (Mallampalli2013Fbxl12).

FBXL12's role as a functional growth inhibitor suggests its potential as a target for mechanism-based therapies, as its levels increase in response to known inducers of G1 arrest, indicating its involvement in cellular response to growth inhibition signals (Mallampalli2013Fbxl12).

## Clinical Significance
Mutations and alterations in the FBXL12 gene have been implicated in various diseases and conditions. FBXL12 is part of the SCF ubiquitin ligase complex, which is involved in the ubiquitination and degradation of target proteins, including the cyclin-dependent kinase inhibitor p21. This regulation is crucial for cell cycle control and DNA repair processes (Tsuruta2016SCFFbl12). A somatic mutation in FBXL12 has been identified in renal carcinoma, suggesting a potential link between FBXL12 mutations and cancer, although the clinical significance of this mutation is not fully understood (Tsuruta2016SCFFbl12).

In the context of cancer, F-box proteins, including FBXL12, are involved in maintaining cancer stemness, which contributes to tumor growth, metastasis, and therapeutic resistance. The deregulation of these proteins is associated with cancer pathogenesis and treatment challenges (Khan2021Fbox). 

In Baladi goats, alterations in FBXL12 expression levels have been associated with diarrhea susceptibility. The gene was found to be upregulated in diarrheic goats, indicating a potential role in disease susceptibility (AlSharif2023New). However, the specific clinical implications of FBXL12 mutations in humans remain to be fully elucidated.

## Interactions
FBXL12, an F-box protein, is involved in several key interactions that regulate cell cycle progression. It specifically targets calmodulin kinase I (CaMKI) for degradation via the proteasomal pathway. This interaction is crucial for the regulation of the cyclin D1/cdk4 complex, as the degradation of CaMKI by FBXL12 leads to reduced phosphorylation of the cyclin-dependent kinase inhibitor p27, affecting its localization and function (Mallampalli2013Fbxl12).

FBXL12 binds to CaMKI, facilitating its ubiquitination and subsequent degradation. This interaction is confirmed through immunoprecipitation and co-immunoprecipitation assays, demonstrating that both endogenous and ectopically expressed FBXL12 can bind to CaMKI (Mallampalli2013Fbxl12). The interaction between FBXL12 and CaMKI is modulated by factors such as calcium and lipopolysaccharide (LPS), which influence the binding affinity between these proteins (Mallampalli2013Fbxl12).

FBXL12 also affects the phosphorylation of p27 at specific threonine residues, which is crucial for the formation of the cdk4/cyclin D1/p27 complex and the intracellular localization of p27 (Mallampalli2013Fbxl12). These interactions highlight the role of FBXL12 in modulating cell cycle-related protein complexes and signaling pathways.


## References


[1. (Tsuruta2016SCFFbl12) Fuminori Tsuruta, Ai Takebe, Kousuke Haratake, Yoshinori Kanemori, Jaehyun Kim, Tomoyuki Endo, Yu Kigoshi, Tomomi Fukuda, Hatsumi Miyahara, Manato Ebina, Tadashi Baba, and Tomoki Chiba. Scffbl12 increases p21waf1/cip1 expression level through atypical ubiquitin chain synthesis. Molecular and Cellular Biology, 36(16):2182–2194, August 2016. URL: http://dx.doi.org/10.1128/MCB.00174-16, doi:10.1128/mcb.00174-16. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00174-16)

[2. (Khan2021Fbox) Abdul Q. Khan, Maha Al-Tamimi, Shahab Uddin, and Martin Steinhoff. F-box proteins in cancer stemness: an emerging prognostic and therapeutic target. Drug Discovery Today, 26(12):2905–2914, December 2021. URL: http://dx.doi.org/10.1016/j.drudis.2021.07.006, doi:10.1016/j.drudis.2021.07.006. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.drudis.2021.07.006)

[3. (Mallampalli2013Fbxl12) Rama K. Mallampalli, Leah Kaercher, Courtney Snavely, Roopa Pulijala, Bill B. Chen, Tiffany Coon, Jing Zhao, and Marianna Agassandian. Fbxl12 triggers g1 arrest by mediating degradation of calmodulin kinase i. Cellular Signalling, 25(10):2047–2059, October 2013. URL: http://dx.doi.org/10.1016/j.cellsig.2013.05.012, doi:10.1016/j.cellsig.2013.05.012. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2013.05.012)

[4. (AlSharif2023New) Mona Al-Sharif and Ahmed Ateya. New insights on coding mutations and mrna levels of candidate genes associated with diarrhea susceptibility in baladi goat. Agriculture, 13(1):143, January 2023. URL: http://dx.doi.org/10.3390/agriculture13010143, doi:10.3390/agriculture13010143. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/agriculture13010143)